Back to Search
Start Over
In VivoEvolution to Colistin Resistance by PmrB Sensor Kinase Mutation in KPC-Producing Klebsiella pneumoniaeIs Associated with Low-Dosage Colistin Treatment
- Source :
- Antimicrobial Agents and Chemotherapy; June 2014, Vol. 58 Issue: 8 p4399-4403, 5p
- Publication Year :
- 2014
-
Abstract
- ABSTRACTColistin is a key drug for the treatment of infections caused by extensively drug-resistant strains of Enterobacteriaceaeproducing carbapenemases. However, the emergence of colistin resistance is being increasingly reported, especially among Klebsiella pneumoniaestrains producing KPC-type carbapenemases (KPC-KP). In this work, we investigated colistin-susceptible (KPB-1) and colistin-resistant (KPB-2) sequential isolates obtained from a patient with a KPC-KP infection before and after low-dosage colistin treatment, respectively. By using a next-generation sequencing approach and comparative genomic analysis of the two isolates, we detected in KPB-2 a nonsynonymous nucleotide substitution in the gene encoding the PmrB sensor kinase, resulting in a leucine-to-arginine substitution at amino acid position 82. Compared with KPB-1, KPB-2 exhibited upregulated transcription of pmrAand of pmrK, which is part of the pmrHFIJKLMoperon responsible for modification of the colistin lipopolysaccharide target. Complementation with wild-type pmrBin KPB-2 restored colistin susceptibility and reduced the transcription of pmrAand pmrKto basal levels, while expression of PmrBL82Rin KPB-1 did not alter colistin susceptibility or upregulate pmrAand pmrKexpression, confirming the dominance of wild-type PmrB versus the PmrBL82Rmutant. The present results indicated that PmrB mutations mediating colistin resistance may be selected during low-dosage colistin treatment. The colistin-resistant phenotype of KPB-2 was stable for up to 50 generations in the absence of selective pressure and was not associated with a significant fitness cost in a competition experiment.
Details
- Language :
- English
- ISSN :
- 00664804 and 10986596
- Volume :
- 58
- Issue :
- 8
- Database :
- Supplemental Index
- Journal :
- Antimicrobial Agents and Chemotherapy
- Publication Type :
- Periodical
- Accession number :
- ejs33311202
- Full Text :
- https://doi.org/10.1128/AAC.02555-14